Alyeska Investment Group’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-83,862
Closed -$293K 727
2025
Q3
$293K Buy
+83,862
New +$287K ﹤0.01% 569
2024
Q3
Sell
-83,862
Closed -$38.6K 686
2024
Q2
$38.6K Buy
+83,862
New +$71.6K ﹤0.01% 550
2024
Q1
Sell
-83,862
Closed -$171K 619
2023
Q4
$171K Buy
+83,862
New +$145K ﹤0.01% 481

Other funds holding TOI

Alyeska Investment Group's TOI Position: Q4 2021 in Review

Alyeska Investment Group sold out of The Oncology Institute (TOI) in Q4 2021, closing a stake of 235,448 shares — an estimated $2.34M sold.

Alyeska Investment Group first reported a position in TOI in Q3 2020 and held it in 5 quarters. The position peaked at $2.54M in Q4 2020. 21 funds tracked by Wall St. Rank hold TOI as of Q4 2021.

  • Alyeska Investment Group reported no remaining The Oncology Institute position as of Q4 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 235,448 The Oncology Institute shares in Q4 2021, an estimated $2.34M.
  • Alyeska Investment Group first reported a position in The Oncology Institute in Q3 2020 and held it in 5 quarters.
  • Alyeska Investment Group's The Oncology Institute position peaked at $2.54M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held The Oncology Institute as of Q4 2021.

Based on Alyeska Investment Group's 13F filing for Q4 2021, filed 14 Feb 2022.